Savara (SVRA) Cash from Investing Activities (2010 - 2026)
Savara (SVRA) reported Cash from Investing Activities of $38.8 million for Q1 2026, up 32.22% year-over-year from $29.3 million in Q1 2025, and up 141.45% on a QoQ basis from -$93.6 million in Q4 2025.
Savara (SVRA) has 17 years of Cash from Investing Activities data on file, last reported at $38.8 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 32.22% year-over-year to $38.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.0 million (up 58.0% YoY) and the FY2025 annual result came in at -$18.4 million, up 53.83% from the prior year.
- Cash from Investing Activities advanced to $38.8 million in Q1 2026 per SVRA's latest filing, from -$93.6 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $53.7 million in Q1 2022 and bottomed at -$98.2 million in Q3 2024.
- The 5-year median for Cash from Investing Activities is $17.9 million (2024), against an average of -$1.4 million.
- The widest annual swing landed in 2022, when Cash from Investing Activities sank 4569.64%; it then soared 3036.18% in 2024.
- Tracing SVRA's Cash from Investing Activities over 5 years: stood at -$59.2 million in 2022, then jumped by 111.1% to $6.6 million in 2023, then jumped by 172.33% to $17.9 million in 2024, then tumbled by 622.85% to -$93.6 million in 2025, then jumped by 141.45% to $38.8 million in 2026.
- Per Business Quant, the three latest SVRA Cash from Investing Activities figures stand at $38.8 million (Q1 2026), -$93.6 million (Q4 2025), and $21.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | 38.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.78 Mn |
| Mar 31, 2026 | 38.78 Mn |
| Dec 31, 2025 | -93.56 Mn |
| Dec 31, 2025 | -93.56 Mn |
| Sep 30, 2025 | 21.47 Mn |
| Sep 30, 2025 | 21.47 Mn |
| Jun 30, 2025 | 24.33 Mn |
| Jun 30, 2025 | 24.33 Mn |
| Mar 31, 2025 | 29.33 Mn |
| Mar 31, 2025 | 29.33 Mn |
| Dec 31, 2024 | 17.90 Mn |
| Dec 31, 2024 | 17.90 Mn |
| Sep 30, 2024 | -98.17 Mn |
| Sep 30, 2024 | -98.17 Mn |
| Jun 30, 2024 | 29.54 Mn |
| Jun 30, 2024 | 29.54 Mn |
| Mar 31, 2024 | 10.79 Mn |
| Mar 31, 2024 | 10.79 Mn |
| Dec 31, 2023 | 6.57 Mn |
| Dec 31, 2023 | 6.57 Mn |
| Sep 30, 2023 | -56.59 Mn |
| Sep 30, 2023 | -56.59 Mn |
| Jun 30, 2023 | -1.01 Mn |
| Jun 30, 2023 | -1.01 Mn |
| Mar 31, 2023 | -6.10 Mn |
| Mar 31, 2023 | -6.10 Mn |
| Dec 31, 2022 | -59.21 Mn |
| Dec 31, 2022 | -59.21 Mn |
| Sep 30, 2022 | 33.00 Mn |
| Sep 30, 2022 | 33.00 Mn |
| Jun 30, 2022 | 25.20 Mn |
| Jun 30, 2022 | 25.20 Mn |
| Mar 31, 2022 | 53.67 Mn |
| Mar 31, 2022 | 53.67 Mn |
| Dec 31, 2021 | -1.27 Mn |
| Dec 31, 2021 | -1.27 Mn |
| Sep 30, 2021 | 12.98 Mn |
| Sep 30, 2021 | 12.98 Mn |
| Jun 30, 2021 | -3.43 Mn |
| Jun 30, 2021 | -3.43 Mn |
| Mar 31, 2021 | -77.74 Mn |
| Mar 31, 2021 | -77.74 Mn |
| Dec 31, 2020 | -381,000.00 |
| Dec 31, 2020 | -381,000.00 |
| Sep 30, 2020 | -6.86 Mn |
| Sep 30, 2020 | -6.86 Mn |
| Jun 30, 2020 | 18.08 Mn |
| Jun 30, 2020 | 18.08 Mn |
| Mar 31, 2020 | -1.79 Mn |
| Mar 31, 2020 | -1.79 Mn |
| Dec 31, 2019 | 16.75 Mn |
| Dec 31, 2019 | 16.75 Mn |
| Sep 30, 2019 | 6.59 Mn |
| Sep 30, 2019 | 6.59 Mn |
| Jun 30, 2019 | -14.92 Mn |
| Jun 30, 2019 | -14.92 Mn |
| Mar 31, 2019 | 7.32 Mn |
| Mar 31, 2019 | 7.32 Mn |
| Dec 31, 2018 | 869,000.00 |
| Dec 31, 2018 | 869,000.00 |
| Sep 30, 2018 | -35.71 Mn |
| Sep 30, 2018 | -35.71 Mn |
| Jun 30, 2018 | 11.83 Mn |
| Jun 30, 2018 | 11.83 Mn |
| Mar 31, 2018 | 9.39 Mn |
| Mar 31, 2018 | 9.39 Mn |
| Dec 31, 2017 | -39.05 Mn |
| Dec 31, 2017 | -39.05 Mn |
| Sep 30, 2017 | -33.44 Mn |
| Sep 30, 2017 | -33.44 Mn |
| Jun 30, 2017 | 3.44 Mn |
| Jun 30, 2017 | 3.44 Mn |
| Mar 31, 2017 | -59,000.00 |
| Mar 31, 2017 | -59,000.00 |
| Sep 30, 2016 | -3,000.00 |
| Sep 30, 2016 | -3,000.00 |
| Jun 30, 2016 | -4.38 Mn |
| Jun 30, 2016 | -4.38 Mn |
| Mar 31, 2016 | 4.38 Mn |
| Mar 31, 2016 | 4.38 Mn |
| Dec 31, 2015 | -296,000.00 |
| Dec 31, 2015 | -296,000.00 |
| Sep 30, 2015 | 4.43 Mn |
| Sep 30, 2015 | 4.43 Mn |
| Jun 30, 2015 | -221,000.00 |
| Jun 30, 2015 | -221,000.00 |
| Mar 31, 2015 | -519,000.00 |
| Mar 31, 2015 | -519,000.00 |
| Dec 31, 2014 | -4.40 Mn |
| Dec 31, 2014 | -4.40 Mn |
| Sep 30, 2014 | 2.81 Mn |
| Sep 30, 2014 | 2.81 Mn |
| Jun 30, 2014 | -392,000.00 |
| Jun 30, 2014 | -392,000.00 |
| Mar 31, 2014 | 2.46 Mn |
| Mar 31, 2014 | 2.46 Mn |
| Dec 31, 2013 | 426,378.00 |
| Dec 31, 2013 | 426,378.00 |
| Sep 30, 2013 | -10.73 Mn |
| Sep 30, 2013 | -10.73 Mn |
| Jun 30, 2013 | 2.14 Mn |
| Jun 30, 2013 | 2.14 Mn |
| Mar 31, 2013 | 3.40 Mn |
| Mar 31, 2013 | 3.40 Mn |
| Dec 31, 2012 | -253,266.00 |
| Dec 31, 2012 | -253,266.00 |
| Sep 30, 2012 | -702,993.00 |
| Sep 30, 2012 | -702,993.00 |
| Jun 30, 2012 | -2.15 Mn |
| Jun 30, 2012 | -2.15 Mn |
| Mar 31, 2012 | -4.06 Mn |
| Mar 31, 2012 | -4.06 Mn |
| Dec 31, 2011 | -1.82 Mn |
| Dec 31, 2011 | -1.82 Mn |
| Sep 30, 2011 | -5.71 Mn |
| Sep 30, 2011 | -5.71 Mn |
| Jun 30, 2011 | -9,680.00 |
| Jun 30, 2011 | -9,680.00 |
| Mar 31, 2011 | -2,223.00 |
| Mar 31, 2011 | -2,223.00 |
| Dec 31, 2010 | -19,054.00 |
| Dec 31, 2010 | -19,054.00 |
| Sep 30, 2010 | 1,700.00 |
| Sep 30, 2010 | 1,700.00 |